T32 SEMINAR: Involuntary Drug Treatment for Individuals with Opioid Use Disorder in Massachusetts
THIS EVENT HAS BEEN POSTPONED. NEW DATE NOT YET AVAILABLE. WE APOLOGIZE FOR ANY INCONVENIENCE!
OPEN TO THE PUBLIC. LIVESTREAM AVAILABLE. REGISTRATION REQUIRED.
Despite its troubling record in international settings, involuntary drug treatment has become an increasingly central feature of the response to the opioid crisis in the United States. After detailing ethical, legal, and public health concerns about civil commitment of people with substance use disorder, presenter Leo Beletsky will focus on what programs and policies can better meet the needs of families without resorting to coercive and counterproductive modalities.
Leo Beletsky, JD, MPH, is an associate professor in law and health sciences at Northeastern University, with a joint appointment in the School of Law and the Bouvé College of Health Sciences. His expertise is on the use of law to improve health, with a focus on drug policy, reducing the spread of HIV and other infectious diseases, and the role of the criminal justice system in shaping public health outcomes. Prof. Beletsky was formerly on the faculty of the Division of Global Public Health at the University of California, San Diego School of Medicine, where he retains an adjunct appointment.
This is a program of the T32 HIV, Substance Abuse and Criminal Justice Fellowship Program, which provides training to the next generation of pre- and post-doctoral scholars in the prevention, treatment, and care of HIV and drug abuse among individuals in the criminal justice system with a strong emphasis on individuals involved in alternatives to incarceration and community supervision (e.g., diversion programs, probation, and community and drug courts) who are affected by health disparities. It is the first NIDA-grant-supported multidisciplinary training program, bringing together 32 faculty members from the Columbia School of Social Work and the Mailman School of Public Health, for interdisciplinary mentoring.
For more information and to register for the event, please click here.